Several European countries have suspended the AstraZeneca vaccine rollout as health authorities investigate 30 cases of “thromboembolic events” or blood clots.
A person was hospitalised with a pulmonary embolism and there were two further cases of thromboembolic cases linked to the vaccine.
On Wednesday, the European Medicines Agency (EMA) published its view on several side effects allegedly caused by the AstraZeneca vaccine rollout in Austria.
The EMA has stated that the vaccine can continue to be administered as “there is currently no indication that vaccination has caused these conditions, which are not listed as side-effects with this vaccine”.
Austria, Denmark, Estonia, Lithuania, Luxembourg and Latvia have suspended the inoculations with the AstraZeneca vaccine, while the UK stated it would continue with its own rollout.